McNeil Voluntary Recalls

McNeil Consumer Healthcare,

Division of McNeil-PCC, Inc., is initiating voluntary recalls. 

The first voluntary recall includes certain product lots of

• Children's TYLENOL® (acetaminophen) and
• Children's ZYRTEC® syrup (cetirizine HCI).

The Company is initiating this recall at the wholesale and retail levels after determining that a small number of product bottles supplied from one of their external suppliers have specific areas where the bottle plastic is thinner than required by their standard specifications.

As of the date of the recall there had been no reports of adverse events caused by the "thin-walled" bottle defect. The possibility of serious adverse events arising from the use of the product packaged in these bottles is remote, however, as a precaution McNeil is initiating a voluntary recall at the warehouse and retail level for the affected lots. They are initiating the recall because the product may not maintain stability over time due to increased light exposure once the bottle is removed from the outer carton.

    See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.

The second recall is also a voluntary recall on certain product lots of

• Infants' TYLENOL® (acetaminophen),
• Infants' MOTRIN® (ibuprofen), and
• Children's ZYRTEC® Sugar-Free, Dye-Free Bubblegum syrup 15mL bottle physician samples (cetirizine HCI 1mg/mL oral solution antihistamine) distributed in the United States.

The Company is initiating the recall at the wholesale level because the potential exists for the product lot number and/or expiration date printed on the bottle to become illegible as a result of consumer handling over the life of the product. To date there have been no reports of adverse events caused by this labeling issue. There are no indications that the absence of these lot numbers and expiration dates will cause adverse events.

     See TylenolProfessional.com or ZyrtecProfessional.com for a Full Product Recall list.

These are not consumer level recalls. However, patients with general questions should call our Consumer Care Center at 1-888-543-8255 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time).

McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants' and Children's Products  

McNeil Consumer Healthcare is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children's and Infants' liquid products manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait. 

McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.  For more information please click on the following link.

http://www.mcneilproductrecall.com/page.jhtml?id=/include/new_recall.inc#

1998 study linking MMR vaccine to autism has been retracted

The Lancet Journal retracts the controversial study linking the MMR (measles, mumps and rubella) vaccine to autism and gastrointestinal problems.  

For more information, please click on the links below.

  Study Linking Autism to MMR Vaccine Retracted  

The New York Times article